Inhibins and activins in pregnancy

Molecular and Cellular Endocrinology

Volumn 225, Issue 1-2, 2004, Pages 93-100

  Florio, P ^a   Luisi, S ^a   Ciarmela, P ^a   Severi, F M ^a   Bocchi, C ^a   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Abortion; Activin A; Betaglycan; Doppler; FLRG; Inhibin A; Placenta; Pre eclampsia; Tumors

Indexed keywords

ACTIVIN; ACTIVIN A; BINDING PROTEIN; FOLLISTATIN; INHIBIN; INHIBIN A;

AMNION FLUID; CELL VIABILITY; CONFERENCE PAPER; DECIDUA; FETUS HYPOXIA; FETUS MEMBRANE; FOLLOW UP; GENE EXPRESSION; HUMAN; HYPERTENSION; IMMINENT ABORTION; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM; MEASUREMENT; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN SECRETION; TROPHOBLAST; UMBILICAL CORD BLOOD;

ACTIVINS; FEMALE; FETAL DEVELOPMENT; FOLLISTATIN-RELATED PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INHIBINS; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 4644307085     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.02.018     Document Type: Conference Paper

References (63)

1. Aquilina J., Maplethorpe R., Ellis P., Harrington K. Correlation between second trimester maternal serum inhibin-A and human chronic gonadotrophin for the prediction of pre-eclampsia. Placenta. 21:2000;487-492
2. Badonnel Y., Barbe F., Legagneur H., Poncelet E., Schweitzer M. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chronic gonadotrophin and its free beta-sub unit. Clin. Endocrinol. (Oxf.). 41:1994;155-162
3. Bersinger N.A., Groome N., Muttukrishna S. Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term. Eur. J. Endocrinol. 147:2002;785-793
4. Blackburn C.A., Keelan J.A., Taylor R.S., North R.A. Maternal serum activin A is not elevated before preeclampsia in women who are at high risk. Am J. Obstet. Gynecol. 188:2003;807-811
5. Blumenstein M., Mitchell M.D., Groome N.P., Keelan J.A. Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta. 23:2002;735-741
6. Bobrow C.S., Holmes R.P., Muttukrishna S., Mohan A., Groome N., Murphy D.J., Soothill P.W. Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound. Am. J. Obstet. Gynecol. 186:2002;283-287
7. Breit S., Ashman K., Wilting J., Rossler J., Hatzi E., Fotsis T., Schweigerer L. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res. 60:2000;4596-4601
8. Campbell S., Pearce J.M., Hackett G., Cohen-Overbeek T., Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet.Gynecol. 68:1986;649-653
9. Caniggia I., Lye S.J., Cross J.C. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology. 138:1997;3976-3986
10. Ciarmela, P., Florio, P., Toti, P., Franchini, A., Maguer-Satta, V., Ginanneschi, C., Ottaviani, E., Petraglia, F., 2003a. Human placenta and fetal membranes express follistatin-related gene (FLRG) mRNA and protein. J. Endocrinol. Invest. 26, 641-645.
11. Ciarmela P, Florio P, Toti P, Grasso D, Santopietro R, Tosi P, Petraglia, F., 2003b. Betaglycan expression in pregnant tissues throughout gestation. Eur. J. Endocrinol. 49, 433-437.
12. D'Antona D., Reis F.M., Benedetto C., Evans L.W., Groome N.P., de Kretser D.M., Wallace E.M., Petraglia F. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J. Endocrinol. 165:2000;157-162
13. Debieve F., Beerlandt S., Hubinont C., Thomas K. Gonadotropins, prolactin, inhibin A, inhibin B, and activin A in human fetal serum from midpregnancy and term pregnancy. J. Clin. Endocrinol. Metab. 85:2000;270-274
14. Eramaa M., Heikinheimo K., Tuuri T., Hilden K., Ritvos O. Inhibin/activin subunit mRNA expression in human granulosa-luteal cells. Mol. Cell. Endocrinol. 92:1993;R15-R20
15. Florio P., Lombardo M., Gallo R., Di Carlo C., Sutton S., Genazzani A.R., Petraglia F. Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. Placenta. 17:1996;307-311
16. Florio P., Cobellis L., Luisi S., Ciarmela P., Severi F.M., Bocchi C., Petraglia F. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol. Cell Endocrinol. 180:2001;123-130
17. Florio P., Severi F.M., Cobellis L., Danero S., Bome A., Luisi S., Petraglia F. New clinical markers for hydatidiform mole. Cancer. 94:2002a;2618-2622
18. Florio P., Ciarmela P., Luisi S., Palumbo M.A., Lambert-Messerlian G., Severi F.M., Petraglia F. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Gynecol. Endocrinol. 16:2002b;365-372
19. Florio P., Severi F.M., Bocchi C., Luisi S., Petraglia F. Abruptio placentae and highest maternal serum activin A levels at mid-gestation: a two cases report. Placenta. 24:2003a;279-280
20. Florio, P., Luisi, S., D'Antona, D., Severi, F.M., Rago, G., Petraglia, F., 2003b. Maternal serum inhibin A measurement may predict the pregnancy outcome in women with threatened abortion. Fertil. Steril. 81, 468-470.
21. Florio P., Reis F.M., Pezzani I., Luisi S., Severi F.M., Petraglia F. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultra. Obstet. Gynecol. 21:2003c;165-169
22. Florio P., Calonaci G., Luisi S., Severi F.M., Ignacchiti E., Palumbo M., Bocchi C., Petraglia F. Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein. Gynecol. Endocrinol. 17:2003d;181-185
23. Florio, P., Perrone, S., Luisi, S., Longini, M., Tanganelli, D., Petraglia, F., Buonocore, G., 2003e. Activin A plasma levels at birth: an index of fetal hypoxia in preterm newborn, Pediatr. Res. 54, 696-700.
24. Greenwood C., Impey L., Muttukrishna S., Groome N.P., Redman C.W. Intrauterine growth restriction without pre-eclampsia and associated changes in serum inhibin A and activin A levels: a case report. Placenta. 22:2001;617-618
25. Gray P.C., Bilezikjian L.M., Vale W. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol. Cell. Endocrinol. 188:2002;254-260
26. Hayette S., Gadoux M., Martel S., Bertrand S., Tigaud I., Magaud J.P., Rimokh R. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene. 16:1998;2949-2954
27. Jenkin G., Ward J., Hooper S., O'Connor A., de Kretser D., Wallace E. Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2). Endocrinology. 142:2001;963-966
28. Jones R.L., Salamonsen L.A., Zhao Y.C., Ethier J.F., Drummond A.E., Findlay J.K. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol. Hum. Reprod. 8:2002;363-374
29. Keelan J.A., Taylor R., Schellenberg J.C., Groome N.P., Mitchell M.D., North R.A. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet. Gynecol. 99:2002;267-274
30. Kozian D.H., Ziche M., Augustin H.G. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab. Invest. 76:1997;267-276
31. Lambert-Messerlian G.M., Silver H.M., Petraglia F., Luisi S., Pezzani I., Maybruck W.M., Hogge W.A., Hanley-Yanez K., Roberts J.M., Neveux L.M., Canick J.A. Second-trimester levels of maternal serum human chronic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. J. Soc. Gynecol. Investig. 7:2000;170-174
32. Lockwood G.M., Ledger W.L., Barlow D.H., Groome N.P., Muttukrishna S. Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome. Biol. Reprod. 57:1997;1490-1494
33. Lockwood G.M., Ledger W.L., Barlow D.H., Groome N.P., Muttukrishna S. Identification of the source of inhibins at the time of conception provides a diagnostic role for them in very early pregnancy. Am J. Reprod. Immunol. 40:1998;303-308
34. Luisi S., Florio P., Reis F.M., Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur. J. Endocrinol. 145:2001;225-236
35. Luisi S., Florio P., D'Antona D., Severi F.M., Sanseverino F., Danero S., Petraglia F. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Eur. J. Endocrinol. 148:2003;233-236
36. Magnus P., Bakketeig L.S., Hoffman H. Birth weight of relatives by maternal tendency to repeat small-for-gestational-age (SGA) births in successive pregnancies. Acta Obstet. Gynecol. Scand. Suppl. 165:1997;35-38
37. Manuelpillai U., Schneider-Kolsky M., Dole A., Wallace E.M. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. J. Endocrinol. 171:2001;57-64
38. Manuelpillai U., Schneider-Kolsky M., Thirunavukarasu P., Dole A., Waldron K., Wallace E.M. Effect of hypoxia on placental activin A, inhibin A and follistatin synthesis. Placenta. 24:2003;77-83
39. Mather J.P., Roberts P.E., Krummen L.A. Follistatin modulates activin activity in a cell and tissue-specific manner. Endocrinology. 132:1993;2732-2734
40. McCarthy S.A., Bicknell R. Inhibition of vascular endothelial cell growth by activin A. J. Biol. Chem. 5:1993;268
41. McCluggage W.G., Ashe P., McBride H., Maxwell P., Sloan J.M. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology. 32:1998;252-256
42. McCluggage W.G. Value of inhibin staining in gynecological pathology. Int. J. Gynecol. Pathol. 20:2001;79-85
43. Muttukrishna S., Child T.J., Groome N.P., Ledger W.L. Source of circulating levels of inhibin A. Hum. Reprod. 12:1997;1089-1093
44. Muttukrishna S., North R.A., Morris J., Schellenberg J.C., Taylor R.S., Asselin J., Ledger W., Groome N., Redman C.W. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum. Reprod. 15:2000;1640-1645
45. Muttukrishna S., Jauniaux E., Greenwold N., McGarrigle H., Jivraj S., Carter S., Elgaddal S., Groome N., Regan L. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum. Reprod. 17:2002;3072-3078
46. Pelkey T.J., Frierson H.F. Jr., Mills S.E., Stoler M.H. Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. Hum. Pathol. 30:1999;26-31
47. Petraglia F., Vaughan J., Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5114-5117
48. Petraglia F., Anceschi M.M., Calza L., Garuti G.C., Fusaro P., Giardino L., Genazzani A.R., Vale W. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J. Clin. Endocrinol. Metab. 77:1993;542-548
49. Petraglia F., Gallinelli A., Grande A., Florio P., Ferrari S., Genazzani A.R., Ling N., DePaolo L.V. Local production and action of follistatin in human placenta. J. Clin. Endocrinol. Metab. 78:1994;205-210
50. Petraglia F., Florio P., Nappi C., Genazzani A.R. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr. Rev. 17:1996;156-186
51. Reis F.M., D'Antona D., Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr. Rev. 23:2002;230-257
52. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet. 357:2001;53-56
53. Schneider, E.P., Schulman, H., 1995. Hypertension. In: Copel, J.A., Reed, K.L. (Eds.), Doppler Ultrasound in Obstetrics and Gynecology. Raven Press, New York, pp. 147-155.
54. Schneider-Kolsky M.E., Manuelpillai U., Waldron K., Dole A., Wallace E.M. The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Placenta. 23:2002;294-302
55. Seckl M.J., Fisher R.A., Salerno G., Rees H., Paradinas F.J., Foskett M., et al. Choriocarcinoma and partial hydatidiform moles. Lancet. 356:2000;36-39
56. Shih I.M., Kurman R.J. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int. J. Gynecol. Pathol. 18:1999;144-150
57. Silver H.M.G., Canick J. Maternal serum activin A and inhibin A levels for prediction of preeclampsia in patients evaluated for "R/O preeclampsia" Am. J. Obstet. Gynecol. 186:2000;S84
58. Silver H.M., Lambert-Messerlian G.M., Reis F.M., Diblasio A.M., Petraglia F., Canick J.A. Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia. J. Soc. Gynecol. Investig. 9:2002;308-312
59. Tsuchida K., Matsuzaki T., Yamakawa N., Liu Z., Sugino H. Intracellular and extracellular control of activin function by novel regulatory molecules. Mol. Cell Endocrinol. 180:2001;25-31
60. Schneider-Kolsky M.E., Tong S., Wallace E.M. Maternal and foetal activin A levels: associations with normal and abnormal labour. Placenta. 23:2002;570-574
61. Yohkaichiya T., Fukaya T., Hoshiai H., Yajima A., de Kretser D.M. Inhibin: a new circulating marker of hydatidiform mole? Br. Med. J. 298:1989;1684-1686
62. Wallace E.M., Schneider-Kolsky M.E., Edwards A., Baker L., Jenkin G. Maternal serum activin A levels in association with intrauterine fetal growth restriction. Br. J. Obstet. Gynecol. 110:2003;306-310
63. Zeeman G.G., Alexander J.M., McIntire D.D., Byrd W., Leveno K.J. Inhibin-A and superimposed preeclampsia in women with chronic hypertension. Obstet. Gynecol. 101:2003;232-236